Discover our unique approach for predicting drug efficacy and efficiency
NeuroChart enables precise analysis of EEG signals after administration of your novel molecule, predicting its biological impact. Our capabilities are supported by Experimental technologies and Al-driven methods.
Pipeline
Experimental
Experimental technologies to analyze cellular activities and brain circuits in animal models
The starting point of our experimental pipeline begins with your molecules, selected as the top candidates from your preclinical testing and requiring in-depth in vivo characterization.
The experimental testing process is tailored according to your needs. This comprehensive approach allows us to thoroughly understand the potential biological impact of each molecule. The data is then analyzed with our computational pipelines to extract cellular and EEG biomarkers in the animal model.
Pipeline
Computational
Al-driven methods to translate cellular activity to non-invasive biomarkers that can be easily tracked in humans to predict drug effects.
We offer state of the art computational approaches and AI-based algorithms to analyze your existing clinical data.
Our approach allows the extraction of traditional parameters as well as novel predictive biomarkers, based on our experimental datasets.
This translational concept allows us to link detailed cellular mechanisms from animal models to human EEG biomarkers, with industrial and clinical interest.
We will provide an extensive report detailing the biological action of the molecules. Our reporting will be critical for your decisions (go – no-go) in subsequent clinical trials to predict the efficacy and efficiency of the molecules in humans.
The benefits of partnering with Neurochart
Accelerated drug screening
Accelerates and reduces the costs of evaluating drug efficacy
EEG biomarkers
Supported by precise cellular mechanisms that illustrate the drug’s biological action.
Straightforward interpretation
Delivers clear GO/NO GO reports from complex biological data.
Predictive EEG biomarkers
Enhance the prediction of drug efficacy and safety in human clinical trials.
AI-based stratification of patients with neurological disorders
Leverages the intra-species predictive value of Neurochart’s approach.